跳转至内容
Merck

SML2941

Sigma-Aldrich

Maribavir

≥98% (HPLC)

别名:

(2S,3S,4R,5S)-2-(5,6-Dichloro-2-(isopropylamino)-1H-benzo[d]imidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 1263W94, Benzimidavir, VP-41263

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C15H19Cl2N3O4
分子量:
376.24
分類程式碼代碼:
12352200
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: 2 mg/mL, clear

儲存溫度

−20°C

SMILES 字串

CC(NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@@H]3[C@@H](O)[C@@H](O)[C@H](CO)O3)C

InChI

1S/C15H19Cl2N3O4/c1-6(2)18-15-19-9-3-7(16)8(17)4-10(9)20(15)14-13(23)12(22)11(5-21)24-14/h3-4,6,11-14,21-23H,5H2,1-2H3,(H,18,19)/t11-,12-,13-,14-/m0/s1

InChI 密鑰

KJFBVJALEQWJBS-XUXIUFHCSA-N

生化/生理作用

Maribavir is an orally available antiviral agent under development for treatment and prevention of human cytomegalovirus (HCMV) infection. Maribavir is a potent and selective ATP-competitive inhibitor of HCMV protein kinase pUL97 that blocks viral replication.

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Mirjam Steingruber et al.
Microorganisms, 8(4) (2020-04-09)
Human cytomegalovirus (HCMV) expresses a variety of viral regulatory proteins that undergo close interaction with host factors including viral-cellular multiprotein complexes. The HCMV protein kinase pUL97 represents a viral cyclin-dependent kinase ortholog (vCDK) that determines the efficiency of HCMV replication
Karen K Biron et al.
Antimicrobial agents and chemotherapy, 46(8), 2365-2372 (2002-07-18)
Benzimidazole nucleosides have been shown to be potent inhibitors of human cytomegalovirus (HCMV) replication in vitro. As part of the exploration of structure-activity relationships within this series, we synthesized the 2-isopropylamino derivative (3322W93) of 1H-beta-D-ribofuranoside-2-bromo-5,6-dichlorobenzimidazole (BDCRB) and the biologically unnatural
Valentine Faure Bardon et al.
PloS one, 15(4), e0232140-e0232140 (2020-05-01)
Congenital cytomegalovirus infection can lead to severe sequelae. When fetal infection is confirmed, we hypothesize that fetal treatment could improve the outcome. Maternal oral administration of an effective drug crossing the placenta could allow fetal treatment. Letermovir (LMV) and Maribavir

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门